金城医药：实际控制人收到行政处罚决定书

Core Viewpoint - The company Jin Cheng Pharmaceutical (300233.SZ) has been penalized by the China Securities Regulatory Commission (CSRC) for stock manipulation involving its actual controller Zhao Yeqing and others, resulting in significant financial losses and market bans for the involved parties [1][2]. Group 1: Penalties and Financial Impact - The CSRC has imposed a total fine of 3 million yuan on Zhao Yeqing, Wang Zhen, and Liu Feng, with Zhao Yeqing responsible for 1.5 million yuan, Wang Zhen for 1.2 million yuan, and Liu Feng for 300,000 yuan [2]. - The account group controlled by Zhao Yeqing, Wang Zhen, and Liu Feng incurred actual losses of 7,392,044.45 yuan during the manipulation period [1]. Group 2: Market Bans - Zhao Yeqing has been subjected to a 4-year market ban, while Wang Zhen faces a 3-year ban, preventing them from engaging in securities business or holding positions in listed or non-listed public companies during this period [2].